Concepedia

Publication | Open Access

Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation

DOIFull Paper Access

32

Citations

8

References

2020

Year

Nicola Potere, Marcello Di Nisio, Giulia Rizzo, Matteo La Vella, Ennio Polilli, Adriana Agostinone, Antonella Spacone, Silvio Di Carlo, Alberto Costantini, Antonio Abbate,
International Journal of Infectious Diseases

Abstract

Low-dose subcutaneous TCZ may be a safe and promising therapeutic option administered on top of SOC to prevent disease progression in hospitalised patients with moderate COVID-19 and hyperinflammation.

References

YearCitations

Page 1